Sign in

    Zach Laverty

    Director of Institutional Sales at KeyBanc Capital Markets

    Zach Laverty is a Director of Institutional Sales at KeyBanc Capital Markets, specializing in equity research and sales focused on institutional clients. He is actively involved in covering companies such as Surgery Partners and facilitates strategic discussions between investors and corporate leadership, contributing to opportunities for portfolio optimization and cash flow improvement. Laverty began his career after graduating from Vanderbilt University in 2005 and has held roles at Brownstone before joining KeyBanc Capital Markets, where he has advanced to a senior director position overseeing institutional relationships. He possesses extensive industry knowledge and experience, though specific securities licenses or formal FINRA registrations are not publicly listed.

    Zach Laverty's questions to Surgery Partners (SGRY) leadership

    Zach Laverty's questions to Surgery Partners (SGRY) leadership • Q2 2025

    Question

    Zach Laverty, on behalf of KeyBanc Capital Markets, questioned the company's portfolio optimization strategy, asking about service lines considered less core and the target leverage ratio following these potential actions.

    Answer

    CEO Eric Evans explained that the company is evaluating opportunities to sell or partner on facilities to accelerate leverage reduction and increase cash flow, with a focus on growing core ASC service lines. CFO Dave Doherty reiterated the company's leverage target remains in the 3x range and noted that portfolio optimization could help achieve this goal faster.

    Ask Fintool Equity Research AI